Loading provider…
Loading provider…
Rheumatology Physician in Jacksonville, FL
NPI: 1457319741Primary Practice Location
SHANDS JACKSONVILLE
655 W 8th St, Jacksonville, FL
Primary Employer
University of Florida Jacksonville Physicians, Inc.
ufhealthjax.org
HQ Phone
Get MD Gurjit's Phone Numberphone_androidMobile
Get MD Gurjit's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardWA State Medical License
FL State Medical License
FL State Medical License
2008 - 2026
WA State Medical License
1998 - 2017

American Board of Internal Medicine
Rheumatology
University of Tennessee
Fellowship • Rheumatology
1996 - 1998
Residency • Internal Medicine
1994 - 1997
University of London Faculty of Medicine
Medical School
Until 1990
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 126 | 279 |
| 2 | 76881Complete ultrasound scan of joint | 51 | 73 |
| 3 | 76882Ultrasound of arm or leg | 20 | 28 |
| 4 | G0008Administration of influenza virus vaccine | 13 | 13 |
| 5 | J1040Injection, methylprednisolone acetate, 80 mg | 11 | 19 |
Diagnostic accuracy of salivary gland ultrasound in Sjögren's syndrome: A systematic review and meta-analysis.
Authors: Jasvinder Singh, Karishma Ramsubeik, Laurie Ramrattan
Publication Date: 2020-11
A rare case of aortitis and occlusive iliac thrombus due to Campylobacter fetus bacteremia.
Authors: Malleswari Ravi
Publication Date: 2025-01-15
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: Placebo, BIOLOGICAL: GSK3196165 (Otilimab), DRUG: Tofacitinib 5 mg
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: BIOLOGICAL: Otilimab (GSK3196165), DRUG: csDMARD(s)
Lead Sponsor: GlaxoSmithKline
Collaborators: Iqvia Pty Ltd
Intervention / Treatment: DRUG: csDMARDs, BIOLOGICAL: GSK3196165 (Otilimab), BIOLOGICAL: Sarilumab, DRUG: Placebo to GSK3196165/ Sarilumab